XML 75 R30.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segment Information | 12 Months Ended
--- | ---
Dec. 31, 2013
Segment Reporting [Abstract] |
Segment Information | SEGMENT INFORMATION The company consists of 13 businesses which are aggregated into eight reportable segments based on similar economic characteristics, the nature of the products and production processes, end-use markets, channels of distribution and regulatory environment. The company's reportable segments are Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Chemicals, Performance Materials, Safety & Protection and Pharmaceuticals. The company includes certain embryonic businesses not included in the reportable segments, such as pre-commercial programs, and nonaligned businesses in Other. Major products by segment include: Agriculture (corn hybrids and soybean varieties, herbicides, fungicides and insecticides); Electronics & Communications (photopolymers and electronic materials); Industrial Biosciences (enzymes and bio-based materials); Nutrition & Health (cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients); Performance Chemicals (fluorochemicals, fluoropolymers, specialty and industrial chemicals, and white pigments); Performance Materials (engineering polymers, packaging and industrial polymers, films and elastomers); Safety & Protection (nonwovens, aramids and solid surfaces); and Pharmaceuticals (representing the company's interest in the collaboration relating to Cozaar®/Hyzaar® antihypertensive drugs, which is reported as other income). The company operates globally in substantially all of its product lines. In general, the accounting policies of the segments are the same as those described in Note 1. Exceptions are noted as follows and are shown in the reconciliations below. Segment sales include transfers to another business segment. Products are transferred between segments on a basis intended to reflect, as nearly as practicable, the market value of the products. Segment net assets includes net working capital, net property, plant and equipment, and other noncurrent operating assets and liabilities of the segment. Affiliate net assets (pro rata share) excludes borrowing and other long-term liabilities. Depreciation and amortization includes depreciation on research and development facilities and amortization of other intangible assets, excluding write-down of assets. Prior years' data have been reclassified to reflect the current organizational structure. Effective January 1, 2013, to better indicate operating performance, the company eliminated the allocation of non-operating pension and other postretirement employee benefit costs from segment pre-tax operating income (loss) (PTOI). Segment PTOI is defined as income (loss) from continuing operations before income taxes excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses and interest. Certain reclassifications of prior year data have been made to conform to current year classifications.
| Agriculture | Electronics & Communications | Industrial Biosciences | Nutrition & Health | Performance Chemicals | Performance Materials |  | Safety & Protection | Pharma- ceuticals | Other | Total
2013 |  |  |  |  |  |  |  |  |  |  |
Segment sales | $ | 11,739 |  | $ | 2,549 |  | $ | 1,224 |  | $ | 3,473 |  | $ | 6,703 |  | $ | 6,468 |  |  | $ | 3,884 |  | $ | — |  | $ | 6 |  | $ | 36,046 |
Less: Transfers | 11 |  | 15 |  | 13 |  | — |  | 196 |  | 73 |  |  | 4 |  | — |  | — |  | 312 |
Net sales | 11,728 |  | 2,534 |  | 1,211 |  | 3,473 |  | 6,507 |  | 6,395 |  |  | 3,880 |  | — |  | 6 |  | 35,734 |
PTOI | 2,132 |  | 203 |  | 170 |  | 305 |  | 924 |  | 1,281 |  |  | 694 |  | 32 |  | (372 | ) | 5,369 |
Depreciation and amortization | 358 |  | 105 |  | 81 |  | 271 |  | 242 |  | 173 |  |  | 198 |  | — |  | 1 |  | 1,429 |
Equity in earnings of affiliates | 36 |  | 22 |  | 2 |  | — |  | 19 |  | (16 | ) |  | 23 |  | — |  | (49 | ) | 37 |
Segment net assets | 5,883 |  | 1,435 |  | 2,640 |  | 6,455 |  | 3,933 |  | 3,724 |  | 1 | 3,138 |  | (3 | ) | 156 |  | 27,361 |
Affiliate net assets | 281 |  | 145 |  | 48 |  | 7 |  | 169 |  | 492 |  |  | 106 |  | — |  | 21 |  | 1,269 |
Purchases of property, plant and equipment | 485 |  | 73 |  | 77 |  | 138 |  | 424 |  | 184 |  |  | 109 |  | — |  | 112 |  | 1,602 |
2012 |  |  |  |  |  |  |  |  |  |  |
Segment sales | $ | 10,426 |  | $ | 2,701 |  | $ | 1,180 |  | $ | 3,422 |  | $ | 7,188 |  | $ | 6,447 |  |  | $ | 3,825 |  | $ | — |  | $ | 5 |  | $ | 35,194 |
Less: Transfers | 5 |  | 17 |  | 11 |  | — |  | 247 |  | 91 |  |  | 11 |  | — |  | — |  | 382 |
Net sales | 10,421 |  | 2,684 |  | 1,169 |  | 3,422 |  | 6,941 |  | 6,356 |  |  | 3,814 |  | — |  | 5 |  | 34,812 |
PTOI | 1,669 |  | 222 |  | 159 |  | 270 |  | 1,778 |  | 1,121 |  |  | 562 |  | 62 |  | (474 | ) | 5,369 |
Depreciation and amortization | 337 |  | 113 |  | 79 |  | 288 |  | 245 |  | 182 |  |  | 197 |  | — |  | 1 |  | 1,442 |
Equity in earnings of affiliates | 30 |  | 19 |  | 1 |  | — |  | 28 |  | 42 |  |  | 32 |  | — |  | (53 | ) | 99 |
Segment net assets | 4,756 |  | 1,622 |  | 2,602 |  | 6,641 |  | 3,910 |  | 3,770 |  |  | 3,153 |  | (18 | ) | 77 |  | 26,513 |
Affiliate net assets | 389 |  | 151 |  | 53 |  | 8 |  | 180 |  | 567 |  |  | 106 |  | — |  | 14 |  | 1,468 |
Purchases of property, plant and equipment | 432 |  | 71 |  | 80 |  | 148 |  | 389 |  | 186 |  |  | 118 |  | — |  | 7 |  | 1,431 |
2011 |  |  |  |  |  |  |  |  |  |  |
Segment sales | $ | 9,166 |  | $ | 3,173 |  | $ | 705 |  | $ | 2,460 |  | $ | 7,794 |  | $ | 6,815 |  |  | $ | 3,934 |  | $ | — |  | $ | 40 |  | $ | 34,087 |
Less: Transfers | 1 |  | 19 |  | 7 |  | — |  | 257 |  | 109 |  |  | 13 |  | — |  | — |  | 406 |
Net sales | 9,165 |  | 3,154 |  | 698 |  | 2,460 |  | 7,537 |  | 6,706 |  |  | 3,921 |  | — |  | 40 |  | 33,681 |
PTOI | 1,566 |  | 438 |  | 2 |  | 76 |  | 2,114 |  | 1,079 |  |  | 661 |  | 289 |  | (344 | ) | 5,881 |
Depreciation and amortization | 295 |  | 99 |  | 47 |  | 207 |  | 252 |  | 199 |  |  | 172 |  | — |  | 2 |  | 1,273 |
Equity in earnings of affiliates | 58 |  | 19 |  | (3 | ) | — |  | 43 |  | 74 |  |  | 47 |  | — |  | (47 | ) | 191 |
Segment net assets | 4,975 |  | 1,954 |  | 2,542 |  | 6,279 |  | 3,812 |  | 3,757 |  |  | 3,239 |  | 35 |  | 75 |  | 26,668 |
Affiliate net assets | 330 |  | 197 |  | 52 |  | 1 |  | 201 |  | 445 |  |  | 111 |  | — |  | 34 |  | 1,371 |
Purchases of property, plant and equipment | 420 |  | 198 |  | 61 |  | 115 |  | 326 |  | 197 |  |  | 208 |  | — |  | 5 |  | 1,530 |
1. | Includes assets held for sale related to GLS/Vinyls of $228 as of December 31, 2013. See Note 2 for additional information.
Reconciliation to Consolidated Financial Statements
PTOI to income from continuing operations before income taxes | 2013 | 2012 | 2011
Total segment PTOI | $ | 5,369 |  | $ | 5,369 |  | $ | 5,881 |
Non-operating pension and other postretirement employee benefit costs | (539 | ) | (654 | ) | (540 | )
Net exchange losses, including affiliates | (128 | ) | (215 | ) | (146 | )
Corporate expenses | (765 | ) | (948 | ) | (869 | )
Interest expense | (448 | ) | (464 | ) | (447 | )
Income from continuing operations before income taxes | $ | 3,489 |  | $ | 3,088 |  | $ | 3,879 |
Segment net assets to total assets at December 31, | 2013 | 2012 | 2011
Total segment net assets | $ | 27,361 |  | $ | 26,513 |  | $ | 26,668 |
Corporate assets 1 | 13,498 |  | 10,261 |  | 9,637 |
Liabilities included in segment net assets | 10,640 |  | 10,009 |  | 9,250 |
Assets related to discontinued operations 2 | — |  | 3,076 |  | 3,088 |
Total assets | $ | 51,499 |  | $ | 49,859 |  | $ | 48,643 |
1. | Pension assets are included in corporate assets.
2. | See Note 1 for additional information on the presentation of the Performance Coatings which met the criteria for discontinued operations during 2012.
Other items 1 | Segment Totals | Adjustments | Consolidated Totals
2013 |  |  |  |  |  |
Depreciation and amortization | $ | 1,429 |  | $ | 174 |  | $ | 1,603 |
Equity in earnings of affiliates | 37 |  | 4 |  | 41 |
Affiliate net assets | 1,269 |  | (258 | ) | 1,011 |
Purchases of property, plant and equipment | 1,602 |  | 280 |  | 1,882 |
2012 |  |  |  |  |  |
Depreciation and amortization | $ | 1,442 |  | $ | 271 |  | $ | 1,713 |
Equity in earnings of affiliates | 99 |  | 3 |  | 102 |
Affiliate net assets | 1,468 |  | (305 | ) | 1,163 |
Purchases of property, plant and equipment | 1,431 |  | 362 |  | 1,793 |
2011 |  |  |  |  |  |
Depreciation and amortization | $ | 1,273 |  | $ | 287 |  | $ | 1,560 |
Equity in earnings of affiliates | 191 |  | 1 |  | 192 |
Affiliate net assets | 1,371 |  | (254 | ) | 1,117 |
Purchases of property, plant and equipment | 1,530 |  | 313 |  | 1,843 |
1. | See Note 1 for additional information on the presentation of the Performance Coatings business which met the criteria for discontinued operations during 2012.
Additional Segment Details 2013 included the following pre-tax benefits (charges):
Agriculture 1,3 | $ | (351 | )
Electronics & Communications 3,4 | (131 | )
Industrial Biosciences 3 | 1 |
Nutrition & Health 3 | 6 |
Performance Chemicals 2,3 | (74 | )
Performance Materials 3 | (16 | )
Safety & Protection 3 | 4 |
Other 3 | 5 |
| $ | (556 | )
1. | Included charges of $(425), offset by $73 of insurance recoveries, recorded in Other operating charges associated with the company's process to fairly resolve claims related to the use of Imprelis®. See Note 16 for additional information.
2. | Included a $(72) charge recorded in Other operating charges related to the titanium dioxide antitrust litigation. See Note 16 for additional information.
3. | Included a net $(3) restructuring adjustment consisting of a $16 benefit associated with prior year restructuring programs and a $(19) charge associated with restructuring actions related to a joint venture. The majority of the $16 net reduction recorded in Employee separation/asset related charges, net was due to the achievement of work force reductions through non-severance programs associated with the 2012 restructuring program. The charge of $(19) included $(9) recorded in Employee separation/asset related charges, net and $(10) recorded in Other income, net and was the result of restructuring actions related to a joint venture within the Performance Materials segment. Pre-tax amounts by segment were: Agriculture - $1, Electronics & Communications - $(2), Industrial Biosciences - $1, Nutrition & Health - $6, Performance Chemicals - $(2), Performance Materials - $(16), Safety & Protection - $4; and Other - $5. See Note 3 for additional information.
4. | Included a $(129) impairment charge recorded in Employee separation/asset related charges, net related to an asset grouping within the Electronics & Communications segment. See Note 3 for additional information.
2012 included the following pre-tax benefits (charges):
Agriculture 1,2,3 | $ | (469 | )
Electronics & Communications 3,4,5 | (37 | )
Industrial Biosciences 3 | (3 | )
Nutrition & Health 3 | (49 | )
Performance Chemicals 3,5 | (36 | )
Performance Materials 3,5 | (104 | )
Safety & Protection 3 | (58 | )
Other 3,6 | (126 | )
| $ | (882 | )
1. | Included a $(575) charge recorded in Other operating charges associated with the company's process to fairly resolve claims related to the use of Imprelis®. See Note 16 for additional information.
2. | Included a $117 gain recorded in Other income, net associated with the sale of a business.
3. | Included a $(134) restructuring charge recorded in Employee separation/asset related charges, net primarily as a result of the company's plan to eliminate corporate costs previously allocated to Performance Coatings and cost-cutting actions to improve competitiveness, partially offset by a reversal of prior year restructuring accruals. Charges by segment were: Agriculture - $(11); Electronics & Communications - $(9); Industrial Biosciences - $(3); Nutrition & Health - $(49); Performance Chemicals - $(3); Performance Materials - $(12); Safety & Protection - $(58); and Other - $11. See Note 3 for additional information.
4. | Included a $122 gain recorded in Other income, net associated with the sale of an equity method investment.
5. | Included a $(275) impairment charge recorded in Employee separation/asset related charges, net related to asset groupings, which impacted the segments as follows: Electronics & Communications - $(150); Performance Chemicals - $(33); and Performance Materials - $(92). See Note 3 for additional information.
6. | Included a $(137) charge in Other operating charges primarily related to the company's settlement of litigation with INVISTA.
2011 included the following pre-tax benefits (charges):
Agriculture 1,2 | $ | (225 | )
Industrial Biosciences 3,4 | (79 | )
Nutrition & Health 3,4 | (126 | )
Performance Materials 4,5 | 47 |
Other 4 | (28 | )
| $ | (411 | )
1. | Included a $(50) charge recorded in Research and development expense in connection with a milestone payment associated with a Pioneer licensing agreement. Since this milestone was reached before regulatory approval was secured by Pioneer, it was charged to Research and development expense.
2. | Included a $(175) charge recorded in Other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis®. See Note 16 for additional information.
3. | Included a $(182) charge for transaction related costs and the fair value step-up of inventories that were acquired as part of the Danisco transaction, which impacted the segments as follows: Industrial Biosciences - $(70) and Nutrition & Health - $(112).
4. | Included a $(53) restructuring charge primarily related to severance and related benefit costs associated with the Danisco acquisition impacting the segments as follows: Industrial Biosciences - $(9); Nutrition & Health - $(14); Performance Materials - $(2); and Other - $(28).
5. | Included a $49 benefit recorded in Other income, net associated with the sale of a business.

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration